Aytu BioPharma, Inc. (AYTU)

NASDAQ: AYTU · Real-Time Price · USD

2.390

-0.010 (-0.44%)

Aug 12, 2026, 12:42 PM EDT - Market open

Aytu BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Cap	26	20	17	9	27	138
Market Cap Growth	75.70%	12.21%	97.57%	-66.84%	-80.67%	-22.92%
Enterprise Value	21.88	10.43	12.56	2.2	25.45	112.86
Last Close Price	2.39	2.18	2.92	1.60	13.80	100.20

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Forward PE	-	9.03	-	-	-	-
PS Ratio	0.46	0.29	0.27	0.08	0.28	2.10
PB Ratio	0.73	1.03	0.63	0.22	0.60	1.00

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
EV/Sales Ratio	0.39	0.16	0.19	0.02	0.26	1.72
EV/EBITDA Ratio	-	-	2.45	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Debt / Equity Ratio	0.57	1.05	0.48	0.41	0.41	0.06
Debt / EBITDA Ratio	-	-	2.95	-	-	-
Debt / FCF Ratio	13.27	-	-	-	-	-
Net Debt / Equity Ratio	-0.14	-0.48	-0.18	-0.17	-0.03	-0.18
Net Debt / EBITDA Ratio	3.90	3.73	-0.95	0.80	0.01	0.50
Net Debt / FCF Ratio	-2.98	4.22	2.84	1.29	0.04	0.96
Asset Turnover	0.48	0.55	0.51	0.78	0.48	0.31
Inventory Turnover	2.47	1.74	1.34	3.57	3.27	2.77
Quick Ratio	0.85	0.98	0.70	0.75	0.64	0.71
Current Ratio	1.12	1.26	0.99	1.03	0.93	0.96
Return on Equity (ROE)	-138.28%	-60.76%	-37.33%	-40.76%	-119.62%	-50.12%
Return on Assets (ROA)	-3.43%	-6.26%	-0.99%	-12.45%	-54.45%	-28.23%
Return on Invested Capital (ROIC)	-22.69%	-46.39%	-4.54%	-44.98%	-140.91%	-73.17%
Return on Capital Employed (ROCE)	-7.52%	-13.38%	-2.58%	-24.27%	-95.82%	-41.94%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Buyback Yield / Dilution	-16.94%	-13.39%	-65.81%	-127.22%	-75.54%	-270.57%
Total Shareholder Return	-16.94%	-13.39%	-65.81%	-127.22%	-75.54%	-270.57%

SEC Filings: 10-K · 10-Q